Singapore Population Genomics Program Moves Into Phenotyping Phase With BC Platforms Partnership
NTU Singapore, through its SG100K program, has launched the HELIOS cohort to bring in environmental, lifestyle, and genetic factors in its effort to better understand Asian populations.
Sema4, AdventHealth Collaborate on Analysis-Driven Personalized Health Program
The partners will structure and curate genomic and longitudinal clinical data for AI-based analysis using Sema4's Centrellis cloud-based health intelligence platform.
Seven Bridges, ZS Partner for Multiomics Analytics in Drug Development
The partners hope to provide scalable "one-stop" analytics convenience to ZS's pharmaceutical clients.
Korean Rare Disease Diagnostics Firm 3billion Looks to 2022 IPO, Expansion Into Drug Discovery
Fresh off a $13 million round of venture capital, the company said it sees global potential in analyzing hereditary conditions.
Datavant, Cerebral Palsy Research Network Seek Genetic Clues to CP
Barrow Neurological Institute and the University of Utah will use Datavant technology to link known mutations to phenotypes in the disease registry.